• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: [email protected]

     Name: Index Client Services

    Email: [email protected]

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Super Micro Computer Inc.
    $SMCI
    5/7/2025$39.00Buy
    Needham
    MicroStrategy Incorporated
    $MSTR
    4/29/2025$480.00Buy
    H.C. Wainwright
    Super Micro Computer Inc.
    $SMCI
    4/25/2025$39.00Neutral
    Citigroup
    Nasdaq Inc.
    $NDAQ
    4/17/2025$91.00Neutral → Buy
    Redburn Atlantic
    Nasdaq Inc.
    $NDAQ
    4/8/2025$74.00Overweight → Equal-Weight
    Morgan Stanley
    Palantir Technologies Inc.
    $PLTR
    4/1/2025$90.00Neutral
    Daiwa Securities
    MicroStrategy Incorporated
    $MSTR
    4/1/2025$220.00Neutral → Sell
    Monness Crespi & Hardt
    Super Micro Computer Inc.
    $SMCI
    3/24/2025$40.00 → $32.00Neutral → Sell
    Goldman
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham resumed coverage on Super Micro Computer with a new price target

      Needham resumed coverage of Super Micro Computer with a rating of Buy and set a new price target of $39.00

      5/7/25 8:38:19 AM ET
      $SMCI
      Computer Manufacturing
      Technology
    • H.C. Wainwright initiated coverage on MicroStrategy d/b/a Strategy with a new price target

      H.C. Wainwright initiated coverage of MicroStrategy d/b/a Strategy with a rating of Buy and set a new price target of $480.00

      4/29/25 8:12:45 AM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • Citigroup initiated coverage on Super Micro Computer with a new price target

      Citigroup initiated coverage of Super Micro Computer with a rating of Neutral and set a new price target of $39.00

      4/25/25 8:33:41 AM ET
      $SMCI
      Computer Manufacturing
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    See more
    • Illumina Reports Financial Results for First Quarter of Fiscal Year 2025

      Core Illumina revenue of $1.04 billion for Q1 2025, down 1% from Q1 2024 (flat on a constant currency basis)GAAP operating margin of 15.8% and non-GAAP operating margin of 20.4% for Q1 2025GAAP diluted EPS of $0.82 and non-GAAP diluted EPS of $0.97 for Q1 2025Cash provided by operations of $240 million and free cash flow of $208 million for Q1 2025For fiscal year 2025, we expect:Core Illumina revenue to decline between (1%) and (3%) on a constant currency basis year over year, down from low single digit growth previouslyRevenue outside of the Greater China region expected to grow between 0% and 2% in 2025 on a constant currency basis year over year and includes our estimate reflecting change

      5/8/25 4:13:00 PM ET
      $ILMN
      Medical Specialities
      Health Care
    • Axon reports Q1 2025 revenue of $604 million, up 31% year over year

      SCOTTSDALE, Ariz., May 7, 2025 /PRNewswire/ -- Software & Services revenue grows 39% to $263 millionAnnual recurring revenue grows 34% to $1.1 billionNet income of $88 million supports non-GAAP net income of $115 million and Adjusted EBITDA of $155 millionRaises full year revenue outlook to a range of $2.60 billion to $2.70 billion, up from $2.55 billion to $2.65 billion Fellow shareholders, Axon delivered a strong start to 2025, achieving record quarterly revenue while maintaining healthy margins and reinforcing our foundation for long-term growth through continued product in

      5/7/25 4:01:00 PM ET
      $AXON
      Ordnance And Accessories
      Industrials
    • Supermicro Announces Third Quarter Fiscal Year 2025 Financial Results

      Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced unaudited financial results for its third quarter of fiscal year 2025 ended March 31, 2025. Third Quarter Fiscal Year 2025 Highlights Net sales of $4.60 billion versus $5.68 billion in Q2'25 and $3.85 billion in Q3'24. Gross margin of 9.6% versus 11.8% in Q2'25 and 15.5% in Q3'24. Net income of $109 million versus $321 million in Q2'25 and $402 million in Q3'24. Diluted net income per common share of $0.17 versus $0.51 in Q2'25 and $0.66 in Q3'24. Non-GAAP diluted net income per common share of $0.31 versus $0.59 in Q2'25

      5/6/25 4:05:00 PM ET
      $SMCI
      Computer Manufacturing
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Nasdaq Inc.

      SCHEDULE 13D/A - NASDAQ, INC. (0001120193) (Subject)

      5/9/25 5:31:45 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Illumina Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ILLUMINA, INC. (0001110803) (Filer)

      5/8/25 4:24:10 PM ET
      $ILMN
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Axon Enterprise Inc.

      10-Q - AXON ENTERPRISE, INC. (0001069183) (Filer)

      5/7/25 4:41:36 PM ET
      $AXON
      Ordnance And Accessories
      Industrials

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

      For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

      11/30/20 5:12:14 PM ET
      $MRNA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Illumina Inc.

      SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

      12/6/24 10:11:24 AM ET
      $ILMN
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Illumina Inc.

      SC 13G - ILLUMINA, INC. (0001110803) (Subject)

      12/5/24 7:27:01 PM ET
      $ILMN
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by MicroStrategy Incorporated

      SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

      11/14/24 6:24:12 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP & CFO Kang Andrew bought $127,500 worth of Series A Perpetual Strife Preferred Stock (1,500 units at $85.00) (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      3/24/25 4:09:12 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • EVP & General Counsel Shao Wei-Ming bought $42,500 worth of Series A Perpetual Strife Preferred Stock (500 units at $85.00) (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      3/24/25 4:07:38 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • President & CEO Le Phong bought $510,000 worth of Series A Perpetual Strife Preferred Stock (6,000 units at $85.00) (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      3/24/25 4:05:11 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    See more
    • Supermicro Announces Participation in Upcoming Investor Events

      Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced it is participating in 1x1 meetings in the upcoming investor conferences: Event: J.P. Morgan Global Technology, Media and Communications Conference Date: May 13, 2025 Location: Boston, MA Event: CJS Securities Virtual Conference| Date: May 14, 2025 Event: Bank of America Securities Global Technology Conference Date: June 3, 2025 Location: San Francisco, CA Event: Mizuho Technology Conference Date: June 10, 2025 Location: New York, NY About Super Micro Computer, Inc. Supermicro (NASDAQ:SMCI) is a global leader in Application-Optimiz

      5/9/25 4:05:00 PM ET
      $SMCI
      Computer Manufacturing
      Technology
    • Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2025

      NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 30, 2025, short interest in 3,156 Nasdaq Global MarketSM securities totaled 13,300,707,903 shares compared with 13,211,633,004 shares in 3,143 Global Market issues reported for the prior settlement date of April 15, 2025. The mid-April short interest represents 2.40 days compared with 1.76 days for the prior reporting period. Short interest in 1,636 securities on The Nasdaq Capital MarketSM totaled 2,645,060,429 shares at the end of the settlement date of April 30, 2025, compared with 2,609,354,721 shares in 1,634 securities for the previous reporting period. This represents a 1.00 day average daily vo

      5/9/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Illumina Reports Financial Results for First Quarter of Fiscal Year 2025

      Core Illumina revenue of $1.04 billion for Q1 2025, down 1% from Q1 2024 (flat on a constant currency basis)GAAP operating margin of 15.8% and non-GAAP operating margin of 20.4% for Q1 2025GAAP diluted EPS of $0.82 and non-GAAP diluted EPS of $0.97 for Q1 2025Cash provided by operations of $240 million and free cash flow of $208 million for Q1 2025For fiscal year 2025, we expect:Core Illumina revenue to decline between (1%) and (3%) on a constant currency basis year over year, down from low single digit growth previouslyRevenue outside of the Greater China region expected to grow between 0% and 2% in 2025 on a constant currency basis year over year and includes our estimate reflecting change

      5/8/25 4:13:00 PM ET
      $ILMN
      Medical Specialities
      Health Care
    • Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics

      CAMBRIDGE, Mass., April 29, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Quotient Therapeutics, a company pioneering somatic genomics, today announced that Rahul Kakkar, M.D., will join Flagship Pioneering as CEO-Partner and Quotient Therapeutics as Chief Executive Officer. Dr. Kakkar is a biotech entrepreneur and physician-scientist with nearly 20 years of professional experience founding and building biotechnology companies and practicing medicine. Previously, he served as President and CEO of Tome Biosciences, a genome engineering biotec

      4/29/25 8:00:00 AM ET
      $FHTX
      $MRNA
      $SANA
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Biotechnology: Biological Products (No Diagnostic Substances)
    • Supermicro Appoints New Independent Director and General Counsel

      Industry veteran with deep financial background Scott Angel joins Board Seasoned legal expert Yitai Hu promoted to General Counsel Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced enhancements to its Board of Directors and senior leadership team to support the continued execution of its growth strategy, with the appointments of: Scott Angel as a new independent director: Mr. Angel, who brings nearly four decades of experience in accounting, audit, consulting, and financial advisory, has deep expertise in the technology and semiconductor industries with a focus on risk and complianc

      3/31/25 9:05:00 AM ET
      $SMCI
      Computer Manufacturing
      Technology
    • Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

      Stephen MacMillan to retire from the Board SAN DIEGO, March 25, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive Chair of Illumina's Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister, founder, Managing Partner, and Chief Investment Officer of Corvex Management, will join the Board of Directors on March 28, 2025. Stephen MacMillan, Chairman, President, and CEO of Hologic, who joined the Illumina Board in June 2023, has decided to retire from the board in preparation for the company

      3/25/25 9:00:00 AM ET
      $ILMN
      Medical Specialities
      Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Patten Jarrod M exercised 4,300 shares at a strike of $17.60 and sold $1,759,785 worth of shares (4,300 units at $409.25) (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      5/9/25 6:13:41 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • SVP, Strategy/Corp Development Wedel Christensen Jakob covered exercise/tax liability with 384 shares and returned $42,388 worth of shares to the company (549 units at $77.21), decreasing direct ownership by 7% to 11,808 units (SEC Form 4)

      4 - ILLUMINA, INC. (0001110803) (Issuer)

      5/7/25 4:09:16 PM ET
      $ILMN
      Medical Specialities
      Health Care
    • Director Patten Jarrod M exercised 3,300 shares at a strike of $17.60 and sold $461,900 worth of shares (1,200 units at $384.92), increasing direct ownership by 30% to 9,170 units (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      5/7/25 4:05:04 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology